4133
vs
T
Taiwan Weighted Index
4133
Over the past 12 months, Abnova Taiwan Corp has underperformed Taiwan Weighted Index, delivering a return of -15% compared to the Taiwan Weighted Index's +56% growth.
Stocks Performance
4133 vs Taiwan Weighted Index
Performance Gap
4133 vs Taiwan Weighted Index
Performance By Year
4133 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Abnova Taiwan Corp
Glance View
Abnova Taiwan Corp. is engaged in researching, developing, manufacturing and selling antibodies. The company is headquartered in Taipei City, Taipei. The company went IPO on 2008-05-27. The firm's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The firm's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
